SEQUELLA INC.

Profile

Company Names

SEQUELLA INC.
SEQUELLA INC

Addresses

9610 MEDICAL CENTER DR, SUITE 200, ROCKVILLE, MD 20850

Phone Numbers

301-762-7776

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$11,929,936.00

Number of Funding Rounds:

11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2017-09-07 
$630,589.00 
$3,624,753.00 
$2,994,164.00 
Equity 
10
2016-08-03 
$1,724,250.00 
$3,006,250.00 
$1,282,000.00 
Equity 
9
2014-09-26 
$3,100,000.00 
$3,100,000.00 
$0.00 
Debt 
8
2013-08-28 
$555,000.00 
$2,400,000.00 
$1,845,000.00 
Equity 
7
2012-08-22 
$100,000.00 
$3,000,000.00 
$2,900,000.00 
Equity 
6
2011-10-19 
$50,000.00 
$3,000,000.00 
$2,950,000.00 
Debt 
5
2011-08-01 
$550,000.00 
$4,000,000.00 
$3,450,000.00 
Equity 
4
2011-05-13 
$1,000,000.00 
$1,500,000.00 
$500,000.00 
Debt 
3
2010-02-16 
$2,000,000.00 
$6,000,000.00 
$4,000,000.00 
Debt 
2
2009-08-06 
$1,500,000.00 
$1,800,000.00 
$300,000.00 
Equity 
1
2008-06-15 
$720,097.00 
$720,097.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LEO 
 
EINCK 
EXECUTIVE OFFICER, DIRECTOR
GARY 
 
HORWITH 
EXECUTIVE OFFICER
WILLIAM 
 
HOSKINS 
DIRECTOR
ALAN 
 
KLEIN 
EXECUTIVE OFFICER
KENNETH 
 
LYNN 
DIRECTOR
PAIGE 
 
MACDONALD 
DIRECTOR
DAVID 
 
MCNEELEY 
EXECUTIVE OFFICER
RONALD 
MELTZER 
DIRECTOR
RONALD 
I. 
MELTZER 
DIRECTOR
CAROL 
NACY 
EXECUTIVE OFFICER, DIRECTOR
CAROL 
A. 
NACY 
EXECUTIVE OFFICER, DIRECTOR
MARK 
 
RAMPY 
EXECUTIVE OFFICER
BRADLEY 
 
ROTTER 
DIRECTOR
MARTIN 
ZUG 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-07 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-03 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-09-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-10-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-05-13 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2010-02-16 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-08-06 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2008-06-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
DAVID N. OLSON
LAMPOST CAPITAL, L.C.
NONE
NONE
PAULSON INVESTMENTS
NONE
NONE
LIFE SCIENCE ADVISORY GROUP
NONE
NONE
NONE
LIFE SCIENCE ADVISORY GROUP
NONE
NONE
NONE
NUMODA CAPITAL INNOVATIONS
NONE